Tylenol-maker Kenvue's stock has lost a quarter of its value in 6 months as momentum grows for autism link despite repeated denials | Fortune
Briefly

Tylenol-maker Kenvue's stock has lost a quarter of its value in 6 months as momentum grows for autism link despite repeated denials | Fortune
""a very big factor""
""Tomorrow we're going to have one of the biggest announcement[s]...medically, I think, in the history of our country," Trump said. "I think you're going to find it to be amazing. I think we found an answer to autism.""
President Donald Trump indicated the White House would release information linking prenatal acetaminophen use to autism and described the disclosure as a major medical announcement. The remarks included a claim that acetaminophen is "a very big factor" in autism risk and that an answer to autism may have been found. Kenvue, maker of Tylenol, saw shares fall more than 5% on Monday and has declined about 25% over six months amid recurring claims. HHS Secretary Robert F. Kennedy Jr. has promoted causal links. Numerous public health experts and a 2024 sibling study find no proven causal relationship. Ari Ne'eman said the administration's urgency rests on equating higher diagnoses with higher prevalence.
Read at Fortune
Unable to calculate read time
[
|
]